FDA
approval
· 2023-06-23
FDA Approved: AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Ajanta Pharma USA Inc.)
Summary
FDA approved a supplemental application to add a fixed-dose combination of amlodipine besylate and olmesartan medoxomil from Ajanta Pharma USA Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL (AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL)